Tomorrow! NutraIngredients-USA's Omega-3 Forum
Omega-3s have established themselves as a star player in the dietary supplements category, with retail sales of EPA and DHA supplements in food, drug, mass and natural channels estimated to be $550 million. Expand to include the direct, MLM, internet, practitioner channels, and the number rises to $1.2 billion, according to GOED.
This success has led to significant consolidation in the industry, particularly on the supply side.
The science is also growing almost exponentially with omega-3s being linked to an ever increasing number of health benefits.
But it hasn’t all be plain sailing for omega-3s, with reports of falling or stagnant sales following negative media reports of select studies, and questions over the sustainability of the supply chain.
In this one hour forum, NutraIngredients-USA will dive deeply into the omega-3 waters for answers.
The NutraIngredients-USA Omega-3 Forum will be held on Thursday, April 28 at 11 AM Eastern time, and includes the following expert panellists:
Adam Ismail, Executive Director, GOED
Matthew Roberts, PhD, Chief Scientific Officer, NBTY
Gretchen Vannice, Consultant, Applied Nutrition Consulting, and Author of The Omega-3 Handbook
Sam Wiley, CEO, Wiley’s Finest
Tom Brenna, PhD, Professor, Cornell University
The event will be moderated by Stephen Daniells, PhD, Senior Editor of NutraIngredients-USA
For more information and to register, please click HERE.
The event is supported by DSM and KD Pharma.
DSM is a leading global provider of nutritional lipid solutions including market leading products life’sDHA and MEG-3.
life’sDHA is a vegetarian source of DHA omega-3 from algae that provides important brain and eye benefits throughout life.
life’sOMEGA is a vegetarian source of EPA/DHA omega-3 from algae that provides important heart health benefits throughout life.
MEG-3 is the trusted fish source of EPA/DHA omega-3 fatty acids that provides important heart health benefits throughout life.
KD Pharma was founded in 1988 and specializes in the environmentally-compatible separation and extraction of highly-unsaturated fatty acids – mainly omega-3 fatty acids – from natural oils with supercritical/liquid CO2 (supercritical fluid chromatography [SFC] & supercritical fluid extraction [SFE]). Owing to the high quality and purity (up to 99%) of the oils the omega-3 fatty acids produced from KD Pharma are sold to customer all over the world.
KD Pharma has a certified GMP process, is FDA approved and is also certified according ISO 9001:2008, ISO 14001:2005 and OHSAS 18001:1999.
